Streetbeat News

Earnings

REVG

REV Group has revised its fiscal year 2024 net sales outlook downward to a range of $2.35 billion to $2.45 billion, compared to the previous range of $2.40 billion to $2.50 billion. This adjustment is slightly below the estimated $2.44 billion.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:04 am

REVG

REV Group reported Q3 2024 earnings per share of $0.48, surpassing the expected $0.42, but sales of $579.4 million fell short of the $618.69 million estimate, marking a 14.79% decline from the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:02 am

DKS

Dick's Sporting Goods reported its Q2 2024 financial results, with adjusted EPS of $4.37, surpassing the estimated $3.83. Sales also exceeded expectations, reaching $3.474 billion compared to the forecasted $3.437 billion.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:02 am

CRM

FEPI

IGV

Salesforce (CRM) shares are slightly down despite a strong earnings report and a new acquisition of AI company Tenyx. The acquisition aims to enhance Salesforce's AI capabilities in customer service. Investors can also gain exposure through ETFs like IGV and FEPI.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:02 am

GTLB

NVDA

PD

QQQ

SPY

ZS

US stock futures are down, with the VIX spiking 10% and Bitcoin sliding. Nvidia is down over 1% in premarket trading. Analysts suggest focusing on defensive stocks amid mixed economic data. GitLab surged 17% on earnings, while PagerDuty and Zscaler fell over 14%.

Portfolio Pulse from Shanthi Rexaline

September 04, 2024 | 11:01 am

CIEN

Ciena Corporation reported its Q3 2024 financial results, with adjusted EPS of $0.35, surpassing the estimate of $0.26. The company's sales reached $942.308 million, exceeding the expected $927.210 million.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:01 am

JILL

J.Jill has lowered its 2024 guidance, expecting net sales to be flat to up 1% year-over-year and adjusted EBITDA to decline by 4%-9%. This is due to the loss of a 53rd week in fiscal 2023 and investments in an Order Management System. Excluding these factors, sales are expected to grow 2%-3% with a 1%-6% decline in EBITDA.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:55 am

JILL

J.Jill has provided its financial outlook for Q3 of fiscal 2024, expecting net sales to range from a 1% decrease to a 2% increase year-over-year, and adjusted EBITDA to be between $23 million and $27 million.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:52 am

JILL

J.Jill reported Q2 2024 earnings per share of $1.05, surpassing the analyst estimate of $0.91, despite a year-over-year decrease. Sales also exceeded expectations at $155.242 million, though they were slightly down from the previous year.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 10:47 am

ATHA

ATRA

CNFR

GTLB

WISA

ZS

GitLab shares surged 17% in pre-market trading after reporting better-than-expected Q2 earnings and issuing strong FY25 guidance. Other notable pre-market movers include WiSA Technologies, Conifer Holdings, and Atara Biotherapeutics among gainers, while Athira Pharma and Zscaler saw significant declines.

Portfolio Pulse from Avi Kapoor

September 04, 2024 | 10:39 am